GeneDx 1Q 2023 Earnings Presentation | WGS Investor Update

GeneDx presented its first quarter 2023 earnings results, outlining revenue guidance and strategic initiatives to improve operational efficiency and reduce cash burn. The company shared expectations for achieving profitability by 2025 and provided updates on gross margin profiles and business restructuring efforts. GeneDx focuses on delivering personalized health insights for diagnosis, treatment direction, and drug discovery.